Introduction

Synergy CHC Corp., the company behind the popular Focus Factor brain supplement, has filed for Chapter 11 bankruptcy, citing the loss of its long-standing Costco partnership as a primary catalyst. The filing, submitted in September 2026, marks a dramatic turn for a brand that once relied heavily on the warehouse giant for the majority of its revenue.

What Happened

On July 15, 2026, Costco Wholesale Corporation notified Synergy CHC that it would discontinue carrying Focus Factor products after more than 16 years on its shelves. The decision stripped the company of a revenue stream that accounted for approximately 58 percent of net sales during the fiscal year ended December 31, 2025. In response, Synergy CHC filed for Chapter 11 protection in the U.S. Bankruptcy Court for the District of Columbia, case 26-00465, listing between $1 million and $10 million in assets and $10 million to $50 million in liabilities. The bankruptcy petition also names its DBAs, including Focus Factor Nutrition Labs, and outlines the company's intent to continue operations while exploring restructuring options. Compounding the pressure, Synergy CHC received a Nasdaq listing warning in August 2026 after failing to file its quarterly Form 10-Q on time, which triggered an acceleration notice from lenders demanding immediate repayment of approximately $18.9 million.

Why This Matters

The collapse of a major retail partnership can serve as a make-or-break moment for consumer brands, especially those dependent on a single channel for over half their revenue. For the supplement and functional beverage sector, where shelf space and trust are paramount, the Focus Factor case underscores the risks of overreliance on a single retailer. It also highlights the broader volatility in the consumer health market, where regulatory scrutiny, investor confidence, and supply chain shifts can rapidly alter a company's trajectory. Stakeholders watching the industry will be monitoring how Synergy CHC navigates the bankruptcy process and whether it can rebuild distribution without its former anchor tenant.

Key Takeaways

  • Synergy CHC Corp. filed Chapter 11 bankruptcy on September 4, 2026, in Washington, D.C.
  • Costco's decision to drop Focus Factor products removed a revenue source representing roughly 58 percent of the company's fiscal 2025 sales.
  • The bankruptcy filing lists assets between $1 million and $10 million, and liabilities between $10 million and $50 million.
  • A Nasdaq listing warning in August 2026 followed a delayed quarterly report filing, triggering an acceleration notice from lenders.
  • The company's portfolio includes Focus Factor, a brain health supplement, and Flat Tummy, a women's wellness brand.
  • Synergy CHC continues operating under Chapter 11 while it evaluates strategic alternatives and restructuring paths.

Conclusion

The Focus Factor bankruptcy serves as a cautionary tale about the fragility of brands that hinge on a single retail relationship. As Synergy CHC works through Chapter 11, the industry will be watching closely to see whether the company can diversify its distribution, restore investor confidence, and emerge as a leaner, more resilient player in the competitive consumer health space. Regardless of the outcome, the case reinforces the importance of revenue diversification and proactive financial management for brands aiming for long-term stability.